Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Magnitude 4.8 earthquake hits southern Taiwan
07/15/2025 10:42 PM - Society
Taipower worker electrocuted conducting Chiayi repairs in critical condition
07/15/2025 10:28 PM - Cross-Strait
Japan's defense white paper highlights China's military drills around Taiwan
07/15/2025 10:06 PM - Society
Taiwan plans tighter rules for older drivers to boost road safety
07/15/2025 10:05 PM - Business
TSMC tops 2024 list of corporate taxpayers with over NT$100 billion
07/15/2025 09:56 PM